NFKBIE and B-cell chronic lymphocytic leukemia: NFKBIE mutations result in reduced IκBε protein levels, which in turn implies decreased IκBε–p65 interactions, increased p65 phosphorylation, and nuclear translocation, leading ultimately to prolonged CLL cell survival (42).